Orbimed Advisors as of June 30, 2021
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 157 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 5.1 | $498M | 6.0M | 82.41 | |
| Boston Scientific Corporation (BSX) | 3.1 | $307M | 7.2M | 42.76 | |
| Bristol Myers Squibb (BMY) | 3.1 | $302M | 4.5M | 66.82 | |
| Edgewise Therapeutics (EWTX) | 3.0 | $297M | 14M | 21.33 | |
| Merck & Co (MRK) | 3.0 | $290M | 3.7M | 77.77 | |
| Prelude Therapeutics (PRLD) | 2.9 | $287M | 10M | 28.63 | |
| Horizon Therapeutics Pub L SHS | 2.8 | $274M | 2.9M | 93.64 | |
| Silverback Therapeutics (SPRY) | 2.8 | $270M | 8.7M | 30.89 | |
| Pmv Pharmaceuticals (PMVP) | 2.6 | $250M | 7.3M | 34.16 | |
| Natera (NTRA) | 2.4 | $234M | 2.1M | 113.53 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.2 | $215M | 1.1M | 201.63 | |
| Mirati Therapeutics | 2.1 | $204M | 1.3M | 161.53 | |
| Turning Point Therapeutics I | 1.9 | $184M | 2.4M | 78.02 | |
| Iovance Biotherapeutics (IOVA) | 1.8 | $173M | 6.6M | 26.02 | |
| Ikena Oncology Nonvoting | 1.7 | $167M | 12M | 14.04 | |
| Arcutis Biotherapeutics (ARQT) | 1.7 | $166M | 6.1M | 27.29 | |
| UnitedHealth (UNH) | 1.6 | $156M | 390k | 400.44 | |
| Guardant Health (GH) | 1.6 | $152M | 1.2M | 124.19 | |
| Humana (HUM) | 1.5 | $148M | 335k | 442.72 | |
| Abcellera Biologics (ABCL) | 1.4 | $137M | 6.2M | 22.00 | |
| Abbvie (ABBV) | 1.3 | $132M | 1.2M | 112.64 | |
| Intuitive Surgical Com New (ISRG) | 1.3 | $128M | 140k | 919.64 | |
| Anthem (ELV) | 1.3 | $128M | 336k | 381.80 | |
| Dex (DXCM) | 1.3 | $127M | 297k | 427.00 | |
| Spdr Ser Tr S&p Biotech (XBI) | 1.3 | $127M | 936k | 135.40 | |
| Deciphera Pharmaceuticals | 1.2 | $121M | 3.3M | 36.61 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $120M | 1.2M | 97.32 | |
| Xtant Med Hldgs Com New (XTNT) | 1.2 | $119M | 73M | 1.63 | |
| Edwards Lifesciences (EW) | 1.2 | $117M | 1.1M | 103.57 | |
| Repare Therapeutics Ord (RPTX) | 1.1 | $107M | 3.4M | 31.18 | |
| Gracell Biotechnologies Sponsored Ads | 1.0 | $103M | 7.9M | 13.00 | |
| Neuropace (NPCE) | 1.0 | $96M | 4.0M | 23.79 | |
| Acutus Medical (AFIB) | 0.9 | $93M | 5.5M | 16.98 | |
| Passage Bio | 0.9 | $92M | 7.0M | 13.24 | |
| Kinnate Biopharma | 0.9 | $90M | 3.8M | 23.28 | |
| Stryker Corporation (SYK) | 0.9 | $88M | 337k | 259.73 | |
| Janux Therapeutics (JANX) | 0.9 | $87M | 3.5M | 24.95 | |
| ImmunoGen | 0.9 | $85M | 13M | 6.59 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.9 | $84M | 519k | 161.89 | |
| Progyny (PGNY) | 0.8 | $81M | 1.4M | 59.00 | |
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $79M | 6.1M | 12.96 | |
| Oak Street Health | 0.8 | $78M | 1.3M | 58.57 | |
| Sinovac Biotech SHS | 0.8 | $77M | 2.8M | 27.05 | |
| Adicet Bio (ACET) | 0.8 | $74M | 7.2M | 10.29 | |
| Keros Therapeutics (KROS) | 0.7 | $71M | 1.7M | 42.47 | |
| 89bio (ETNB) | 0.7 | $70M | 3.7M | 18.70 | |
| Theravance Biopharma (TBPH) | 0.7 | $66M | 4.6M | 14.52 | |
| Meiragtx Holdings (MGTX) | 0.6 | $64M | 4.1M | 15.50 | |
| Vectivbio Hldg Ord Shs | 0.6 | $60M | 5.1M | 11.66 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.6 | $59M | 448k | 131.55 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.6 | $57M | 3.0M | 18.85 | |
| Thermo Fisher Scientific (TMO) | 0.6 | $56M | 110k | 504.47 | |
| Singular Genomics Systems In | 0.6 | $55M | 2.0M | 27.48 | |
| Mereo Biopharma Group Ads (Principal) (MREO) | 0.6 | $55M | 17M | 3.17 | |
| Burning Rock Biotech Sponsored Ads | 0.6 | $55M | 1.9M | 29.46 | |
| Select Medical Holdings Corporation (SEM) | 0.5 | $54M | 1.3M | 42.26 | |
| Chemomab Therapeutics Sponsored Ads | 0.5 | $49M | 2.6M | 19.02 | |
| Tela Bio (TELA) | 0.5 | $49M | 3.0M | 16.11 | |
| Applied Therapeutics (APLT) | 0.5 | $47M | 2.3M | 20.78 | |
| Terns Pharmaceuticals (TERN) | 0.5 | $47M | 3.8M | 12.26 | |
| Vistagen Therapeutics Com New | 0.5 | $46M | 15M | 3.15 | |
| Decibel Therapeutics | 0.4 | $43M | 4.9M | 8.60 | |
| Novavax Com New (NVAX) | 0.4 | $43M | 200k | 212.31 | |
| Tricida | 0.4 | $42M | 9.6M | 4.32 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $41M | 2.3M | 17.69 | |
| Ikena Oncology (IKNA) | 0.4 | $41M | 2.9M | 14.04 | |
| Si-bone (SIBN) | 0.4 | $41M | 1.3M | 31.47 | |
| Mersana Therapeutics | 0.4 | $38M | 2.8M | 13.58 | |
| Gemini Therapeutics | 0.4 | $38M | 5.8M | 6.47 | |
| Logicbio Therapeutics | 0.4 | $38M | 8.5M | 4.44 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.4 | $37M | 5.7M | 6.54 | |
| Harpoon Therapeutics | 0.4 | $36M | 2.6M | 13.87 | |
| Nanostring Technologies (NSTGQ) | 0.4 | $36M | 556k | 64.79 | |
| Graphite Bio | 0.3 | $34M | 1.1M | 30.73 | |
| Trillium Therapeutics Com New | 0.3 | $32M | 3.3M | 9.70 | |
| Gh Research Ordinary Shares (GHRS) | 0.3 | $31M | 1.4M | 21.73 | |
| Cullinan Oncology (CGEM) | 0.3 | $30M | 1.1M | 25.75 | |
| Scpharmaceuticals (SCPH) | 0.3 | $29M | 4.8M | 6.11 | |
| Kala Pharmaceuticals | 0.3 | $29M | 5.5M | 5.30 | |
| Sierra Oncology Com New | 0.3 | $29M | 1.5M | 19.47 | |
| D Fluidigm Corp Del (LAB) | 0.3 | $29M | 4.7M | 6.16 | |
| Arcturus Therapeutics Hldg I (ARCT) | 0.3 | $29M | 849k | 33.84 | |
| Curis Com New | 0.3 | $28M | 3.5M | 8.07 | |
| Aeglea Biotherapeutics | 0.3 | $28M | 4.0M | 6.96 | |
| Alexion Pharmaceuticals | 0.3 | $28M | 151k | 183.71 | |
| Alpine Immune Sciences | 0.3 | $28M | 3.1M | 9.00 | |
| Aptose Biosciences Com New | 0.3 | $27M | 8.0M | 3.32 | |
| Fusion Pharmaceuticals | 0.3 | $26M | 3.2M | 8.08 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $25M | 1.3M | 18.62 | |
| Biogen Idec (BIIB) | 0.2 | $23M | 67k | 346.28 | |
| Flexion Therapeutics | 0.2 | $23M | 2.8M | 8.23 | |
| Graybug Vision Com Shs | 0.2 | $23M | 4.2M | 5.43 | |
| Olema Pharmaceuticals (OLMA) | 0.2 | $23M | 808k | 27.98 | |
| Nextcure (NXTC) | 0.2 | $22M | 2.7M | 8.03 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $22M | 8.1M | 2.67 | |
| Imara | 0.2 | $22M | 2.7M | 7.90 | |
| Vaxcyte (PCVX) | 0.2 | $21M | 945k | 22.51 | |
| Galecto | 0.2 | $21M | 4.1M | 5.06 | |
| Magenta Therapeutics | 0.2 | $20M | 2.0M | 9.78 | |
| Gilead Sciences (GILD) | 0.2 | $20M | 288k | 68.86 | |
| Chinook Therapeutics | 0.2 | $19M | 1.3M | 14.12 | |
| Cti Biopharma | 0.2 | $19M | 7.5M | 2.50 | |
| Verrica Pharmaceuticals | 0.2 | $17M | 1.5M | 11.30 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $16M | 231k | 68.89 | |
| Nautilus Biotechnology (NAUT) | 0.2 | $16M | 1.5M | 10.10 | |
| Vor Biopharma (VOR) | 0.2 | $16M | 833k | 18.65 | |
| Achilles Therapeutics Sponsored Ads (ACHL) | 0.2 | $16M | 1.6M | 9.79 | |
| Jounce Therapeutics | 0.1 | $15M | 2.1M | 6.80 | |
| Uniqure Nv SHS (QURE) | 0.1 | $15M | 471k | 30.80 | |
| Synlogic | 0.1 | $14M | 3.7M | 3.89 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $14M | 2.6M | 5.50 | |
| Amgen (AMGN) | 0.1 | $14M | 57k | 243.75 | |
| Relay Therapeutics (RLAY) | 0.1 | $13M | 350k | 36.59 | |
| Alector (ALEC) | 0.1 | $13M | 612k | 20.83 | |
| Chardan Healthcare Acqu- Ord | 0.1 | $13M | 2.3M | 5.46 | |
| Wm Technology (MAPS) | 0.1 | $13M | 700k | 17.86 | |
| Curevac N V Call Option (CVAC) | 0.1 | $13M | 170k | 73.47 | |
| Bellus Health Com New | 0.1 | $12M | 4.0M | 3.10 | |
| Aerovate Therapeutics (AVTE) | 0.1 | $12M | 536k | 22.83 | |
| Oncocyte | 0.1 | $12M | 2.1M | 5.74 | |
| Century Therapeutics (IPSC) | 0.1 | $12M | 407k | 29.34 | |
| Convey Hldg Parent | 0.1 | $11M | 1.0M | 11.38 | |
| CVRX (CVRX) | 0.1 | $11M | 400k | 28.00 | |
| Syros Pharmaceuticals | 0.1 | $10M | 1.8M | 5.45 | |
| Nanostring Technologies Note 2.625% 3/0 (Principal) | 0.1 | $9.7M | 6.0M | 1.62 | |
| Cytomx Therapeutics (CTMX) | 0.1 | $9.6M | 1.5M | 6.33 | |
| 9 Meters Biopharma | 0.1 | $9.4M | 8.6M | 1.10 | |
| I Mab Sponsored Ads (IMAB) | 0.1 | $9.3M | 111k | 83.95 | |
| Catalyst Biosciences Com New | 0.1 | $9.2M | 2.1M | 4.33 | |
| X4 Pharmaceuticals | 0.1 | $8.9M | 1.4M | 6.50 | |
| Aerpio Pharmaceuticals | 0.1 | $8.8M | 5.2M | 1.69 | |
| Aslan Pharmaceuticals Ads | 0.1 | $8.3M | 2.5M | 3.30 | |
| Alx Oncology Hldgs (ALXO) | 0.1 | $8.2M | 150k | 54.68 | |
| Sutro Biopharma (STRO) | 0.1 | $8.1M | 434k | 18.59 | |
| Nurix Therapeutics (NRIX) | 0.1 | $8.0M | 300k | 26.53 | |
| Monte Rosa Therapeutics (GLUE) | 0.1 | $7.9M | 350k | 22.70 | |
| Landos Biopharma | 0.1 | $7.9M | 681k | 11.55 | |
| Dyne Therapeutics (DYN) | 0.1 | $7.4M | 350k | 21.04 | |
| Otonomy | 0.1 | $7.2M | 3.3M | 2.23 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.1 | $6.9M | 500k | 13.78 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $6.4M | 362k | 17.56 | |
| Prometheus Biosciences | 0.1 | $6.1M | 250k | 24.56 | |
| Verve Therapeutics (VERV) | 0.1 | $6.0M | 100k | 60.25 | |
| Pulmonx Corp (LUNG) | 0.1 | $5.5M | 125k | 44.12 | |
| Strongbridge Biopharma Shs Usd | 0.1 | $5.2M | 1.7M | 2.97 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $5.1M | 500k | 10.20 | |
| Organon & Co Common Stock (OGN) | 0.1 | $5.1M | 167k | 30.26 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $5.0M | 65k | 77.74 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $4.4M | 450k | 9.74 | |
| Adagene Ads (ADAG) | 0.0 | $3.7M | 275k | 13.56 | |
| Talaris Therapeutics | 0.0 | $3.6M | 247k | 14.69 | |
| Inozyme Pharma (INZY) | 0.0 | $3.2M | 189k | 17.04 | |
| Inflarx Nv (IFRX) | 0.0 | $3.2M | 1.1M | 2.97 | |
| Kezar Life Sciences | 0.0 | $3.0M | 557k | 5.43 | |
| Longboard Pharmaceuticals In | 0.0 | $1.0M | 114k | 9.12 | |
| Wm Technology *w Exp 06/16/202 Call Option (MAPSW) | 0.0 | $954k | 150k | 6.35 | |
| Purple Biotech Sponsored Ads | 0.0 | $86k | 18k | 4.86 |
